New measure of quality of life for patients with locally recurrent rectal cancer

A new collaborative study between researchers in the UK and Australia is a huge step towards aligning outcome reporting with patient priorities in advanced cancer settings. The study, published in the journal eClinicalMedicine, details the development, testing and analysis of a design-specific measure to assess quality of life in patients with recurrent rectal cancer, regardless of treatment intent.